Search results
Rivian Automotive (NASDAQ:RIVN) Given Overweight Rating at Cantor Fitzgerald
ETF DAILY NEWS· 13 hours agoCantor Fitzgerald reiterated their overweight rating on shares of Rivian Automotive (NASDAQ:RIVN – Free Report) in a research report sent to investors on Monday, Benzinga ...
Is Rivian Stock A Buy Or A Sell As CEO RJ Scaringe Unloads 70,000 Shares?
Investor's Business Daily· 6 days agoRivian Automotive is looking to challenge Tesla, Ford and General Motors with its adventure-styled...
V Square Quantitative Management LLC Buys 2,942 Shares of Rivian Automotive, Inc. (NASDAQ:RIVN)
ETF DAILY NEWS· 12 hours agoV Square Quantitative Management LLC lifted its stake in shares of Rivian Automotive, Inc....
Beyond The Numbers: 15 Analysts Discuss Rivian Automotive Stock - Rivian Automotive (NASDAQ:RIVN)
Benzinga· 20 hours agoDebt Management: Rivian Automotive's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.64 . ... the Relevance of Analyst ...
Should You Buy Rivian Stock While It's Below $15? | The Motley Fool
The Motley Fool· 2 days agoBuilding off this success, Rivian is developing several cheaper options that it expects will hit the...
EV maker files for bankruptcy after hemorrhaging cash
FOX Business· 26 minutes agoHenrik Fisker is out of gas, again. The automotive designer's California-based electric vehicle startup, Fisker, filed for bankruptcy protection late on Monday and will seek to sell its assets ...
Gateway - Jalopnik
Jalopnik· 16 minutes agoEV maker Tesla wants to expand its factory in Austin, Texas to the tune of $775 million, a new study shows traffic crashes cost U.S. society billions, and Tesla is also nearing a deal to set ...
Canoo (GOEV) stock analysis as Tesla wannabe faces a cash squeeze | Invezz
Invezz· 1 day agoThe electric vehicle industry is going through major headwinds this year amid heightened concerns about margins, growth, and balance sheets. Canoo (GOEV) stock price has already ...
S&P 500 Homebuilder Expects Average Home Price To Have Dipped 6% In Q2
Investor's Business Daily· 1 day agoAnalysts expect Miami-based homebuilder Lennar to see earnings grow 7% to $3.23 per share in the second quarter with sales totaling $8.48 billion, up 5% compared to a year ago. Lennar is also ...
...s Donanemab Gains Favorable FDA Advisory Verdict, Boosting Stock Potential, Says BofA Analyst -...
Benzinga· 7 days agoEli Lilly's donanemab for Alzheimer's disease garners positive FDA committee verdict, prompting analyst's bullish outlook amid comparisons to Biogen's Leqembi.
